Ubiquitin conjugation to Gag is essential for ESCRT-mediated HIV-1 budding

Retrovirology

Fadila Bouamr¹  Robert C Piper³  Kunio Nagashima²  Paola Sette¹ 

[1] Viral budding Unit, Laboratory of Molecular Microbiology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 4 Center Dr, Bethesda, MD 20894, USA;Image Analysis Laboratory, Advanced Technology Program, SAIC-Frederick, NCI-Frederick, Frederick, MD 21702, USA;Molecular Physiology and Biophysics, University of Iowa, Iowa City, Iowa 52246, USA

关键词: Gag;    Deubiquitination;    ESCRT;    HIV budding;    Ubiquitin;   

Others  :  1209095
DOI  :  10.1186/1742-4690-10-79

 received in 2013-06-07, accepted in 2013-07-24,  发布年份 2013

【 摘 要 】

Background

HIV-1 relies on the host ESCRTs for release from cells. HIV-1 Gag engages ESCRTs by directly binding TSG101 or Alix. ESCRTs also sort ubiquitinated membrane proteins through endosomes to facilitate their lysosomal degradation. The ability of ESCRTs to recognize and process ubiquitinated proteins suggests that ESCRT-dependent viral release may also be controlled by ubiquitination. Although both Gag and ESCRTs undergo some level of ubiquitination, definitive demonstration that ubiquitin is required for viral release is lacking. Here we suppress ubiquitination at viral budding sites by fusing the catalytic domain of the Herpes Simplex UL36 deubiquitinating enzyme (DUb) onto TSG101, Alix, or Gag.

Results

Expressing DUb-TSG101 suppressed Alix-independent HIV-1 release and viral particles remained tethered to the cell surface. DUb-TSG101 had no effect on budding of MoMLV or EIAV, two retroviruses that rely on the ESCRT machinery for exit. Alix-dependent virus release such as EIAV’s, and HIV-1 lacking access to TSG101, was instead dramatically blocked by co-expressing DUb-Alix. Finally, Gag-DUb was unable to support virus release and dominantly interfered with release of wild type HIV-1. Fusion of UL36 did not effect interactions with Alix, TSG101, or Gag and all of the inhibitory effects of UL36 fusion were abolished when its catalytic activity was ablated. Accordingly, Alix, TSG101 and Gag fused to inactive UL36 functionally replaced their unfused counterparts. Interestingly, coexpression of the Nedd4-2s ubiquitin ligase suppressed the ability of DUb-TSG101 to inhibit HIV-1 release while also restoring detectable Gag ubiquitination at the membrane. Similarly, incorporation of Gag-Ub fusion proteins into virions lifted DUb-ESCRT inhibitory effect. In contrast, Nedd4-2s did not suppress the inhibition mediated by Gag-DUb despite restoring robust ubiquitination of TSG101/ESCRT-I at virus budding sites.

Conclusions

These studies demonstrate a necessary and natural role for ubiquitin in ESCRT-dependent viral release and indicate a critical role for ubiquitination of Gag rather than ubiquitination of ESCRTs themselves.

【 授权许可】

   
2013 Sette et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

【 参考文献 】

• [1]Babst M, Odorizzi G, Estepa EJ, Emr SD: Mammalian tumor susceptibility gene 101 (TSG101) and the yeast homologue, Vps23p, both function in late endosomal trafficking. Traffic 2000, 1:248-258.
• [2]Carlton JG, Martin-Serrano J: Parallels between cytokinesis and retroviral budding: a role for the ESCRT machinery. Science 2007, 316:1908-1912.
• [3]Hurley JH, Hanson PI: Membrane budding and scission by the ESCRT machinery: it's all in the neck. Nat Rev Mol Cell Biol 2010, 11:556-566.
• [4]Sundquist WI, Krausslich HG: HIV-1 assembly, budding, and maturation. Cold Spring Harb Perspect Med 2012, 2:a006924.
• [5]Morita E, Sandrin V, McCullough J, Katsuyama A, Baci Hamilton I, Sundquist WI: ESCRT-III protein requirements for HIV-1 budding. Cell Host Microbe 2011, 9:235-242.
• [6]Weissenhorn W, Gottlinger H: Essential ingredients for HIV-1 budding. Cell Host Microbe 2011, 9:172-174.
• [7]Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Cote M, Rich RL, et al.: Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107:55-65.
• [8]Martin-Serrano J, Zang T, Bieniasz PD: Role of ESCRT-I in retroviral budding. J Virol 2003, 77:4794-4804.
• [9]Fisher RD, Chung HY, Zhai Q, Robinson H, Sundquist WI, Hill CP: Structural and biochemical studies of ALIX/AIP1 and its role in retrovirus budding. Cell 2007, 128:841-852.
• [10]Katoh K, Shibata H, Suzuki H, Nara A, Ishidoh K, Kominami E, Yoshimori T, Maki M: The ALG-2-interacting protein Alix associates with CHMP4b, a human homologue of yeast Snf7 that is involved in multivesicular body sorting. J Biol Chem 2003, 278:39104-39113.
• [11]Bouamr F, Melillo JA, Wang MQ, Nagashima K, de Los Santos M, Rein A, Goff SP: PPPYVEPTAP motif is the late domain of human T-cell leukemia virus type 1 Gag and mediates its functional interaction with cellular proteins Nedd4 and Tsg101 [corrected]. J Virol 2003, 77:11882-11895.
• [12]Jadwin JA, Rudd V, Sette P, Challa S, Bouamr F: Late domain-independent rescue of a release-deficient Moloney murine leukemia virus by the ubiquitin ligase itch. J Virol 2010, 84:704-715.
• [13]Martin-Serrano J, Eastman SW, Chung W, Bieniasz PD: HECT ubiquitin ligases link viral and cellular PPXY motifs to the vacuolar protein-sorting pathway. J Cell Biol 2005, 168:89-101.
• [14]Patnaik A, Chau V, Wills JW: Ubiquitin is part of the retrovirus budding machinery. Proc Natl Acad Sci USA 2000, 97:13069-13074.
• [15]Schubert U, Ott DE, Chertova EN, Welker R, Tessmer U, Princiotta MF, Bennink JR, Krausslich HG, Yewdell JW: Proteasome inhibition interferes with gag polyprotein processing, release, and maturation of HIV-1 and HIV-2. Proc Natl Acad Sci USA 2000, 97:13057-13062.
• [16]Strack B, Calistri A, Accola MA, Palu G, Gottlinger HG: A role for ubiquitin ligase recruitment in retrovirus release. Proc Natl Acad Sci USA 2000, 97:13063-13068.
• [17]Chung HY, Morita E, von Schwedler U, Muller B, Krausslich HG, Sundquist WI: NEDD4L overexpression rescues the release and infectivity of human immunodeficiency virus type 1 constructs lacking PTAP and YPXL late domains. J Virol 2008, 82:4884-4897.
• [18]Sette P, Jadwin JA, Dussupt V, Bello NF, Bouamr F: The ESCRT-associated protein Alix recruits the ubiquitin ligase Nedd4-1 to facilitate HIV-1 release through the LYPXnL L domain motif. J Virol 2010, 84:8181-8192.
• [19]Usami Y, Popov S, Popova E, Gottlinger HG: Efficient and specific rescue of human immunodeficiency virus type 1 budding defects by a Nedd4-like ubiquitin ligase. J Virol 2008, 82:4898-4907.
• [20]Babst M, Katzmann DJ, Estepa-Sabal EJ, Meerloo T, Emr SD: Escrt-III: an endosome-associated heterooligomeric protein complex required for mvb sorting. Dev Cell 2002, 3:271-282.
• [21]Raiborg C, Stenmark H: The ESCRT machinery in endosomal sorting of ubiquitylated membrane proteins. Nature 2009, 458:445-452.
• [22]Shields SB, Piper RC: How ubiquitin functions with ESCRTs. Traffic 2011, 12:1306-1317.
• [23]Joshi A, Munshi U, Ablan SD, Nagashima K, Freed EO: Functional replacement of a retroviral late domain by ubiquitin fusion. Traffic 2008, 9:1972-1983.
• [24]Okumura A, Lu G, Pitha-Rowe I, Pitha PM: Innate antiviral response targets HIV-1 release by the induction of ubiquitin-like protein ISG15. Proc Natl Acad Sci USA 2006, 103:1440-1445.
• [25]Patnaik A, Chau V, Li F, Montelaro RC, Wills JW: Budding of equine infectious anemia virus is insensitive to proteasome inhibitors. J Virol 2002, 76:2641-2647.
• [26]Weiss ER, Popova E, Yamanaka H, Kim HC, Huibregtse JM, Gottlinger H: Rescue of HIV-1 release by targeting widely divergent NEDD4-type ubiquitin ligases and isolated catalytic HECT domains to Gag. PLoS Pathog 2010, 6:e1001107.
• [27]Zhadina M, Bieniasz PD: Functional interchangeability of late domains, late domain cofactors and ubiquitin in viral budding. PLoS Pathog 2010, 6:e1001153.
• [28]Ott DE, Coren LV, Chertova EN, Gagliardi TD, Schubert U: Ubiquitination of HIV-1 and MuLV Gag. Virology 2000, 278:111-121.
• [29]Gottwein E, Jager S, Habermann A, Krausslich HG: Cumulative mutations of ubiquitin acceptor sites in human immunodeficiency virus type 1 gag cause a late budding defect. J Virol 2006, 80:6267-6275.
• [30]Ott DE, Coren LV, Copeland TD, Kane BP, Johnson DG, Sowder RC 2nd, Yoshinaka Y, Oroszlan S, Arthur LO, Henderson LE: Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virus. J Virol 1998, 72:2962-2968.
• [31]Jager S, Gottwein E, Krausslich HG: Ubiquitination of human immunodeficiency virus type 1 Gag is highly dependent on Gag membrane association. J Virol 2007, 81:9193-9201.
• [32]Zhadina M, McClure MO, Johnson MC, Bieniasz PD: Ubiquitin-dependent virus particle budding without viral protein ubiquitination. Proc Natl Acad Sci USA 2007, 104:20031-20036.
• [33]Amit I, Yakir L, Katz M, Zwang Y, Marmor MD, Citri A, Shtiegman K, Alroy I, Tuvia S, Reiss Y, et al.: Tal, a Tsg101-specific E3 ubiquitin ligase, regulates receptor endocytosis and retrovirus budding. Genes Dev 2004, 18:1737-1752.
• [34]Keren-Kaplan T, Attali I, Estrin M, Kuo LS, Farkash E, Jerabek-Willemsen M, Blutraich N, Artzi S, Peri A, Freed EO, et al.: Structure-based in silico identification of ubiquitin-binding domains provides insights into the ALIX-V:ubiquitin complex and retrovirus budding. EMBO J 2013, 32:538-551.
• [35]Pashkova N, Gakhar L, Winistorfer SC, Sunshine AB, Rich M, Dunham MJ, Yu L, Piper RC: The yeast Alix Homolog Bro1 functions as a ubiquitin receptor for protein sorting into multivesicular endosomes. Dev Cell 2013, 25:520-533.
• [36]Pornillos O, Alam SL, Davis DR, Sundquist WI: Structure of the Tsg101 UEV domain in complex with the PTAP motif of the HIV-1 p6 protein. Nat Struct Biol 2002, 9:812-817.
• [37]Dowlatshahi DP, Sandrin V, Vivona S, Shaler TA, Kaiser SE, Melandri F, Sundquist WI, Kopito RR: ALIX Is a Lys63-specific polyubiquitin binding protein that functions in retrovirus budding. Dev Cell 2012, 23:1247-33.
• [38]Stringer DK, Piper RC: A single ubiquitin is sufficient for cargo protein entry into MVBs in the absence of ESCRT ubiquitination. J Cell Biol 2011, 192:229-242.
• [39]Pornillos O, Alam SL, Rich RL, Myszka DG, Davis DR, Sundquist WI: Structure and functional interactions of the Tsg101 UEV domain. EMBO J 2002, 21:2397-2406.
• [40]Lee S, Joshi A, Nagashima K, Freed EO, Hurley JH: Structural basis for viral late-domain binding to Alix. Nat Struct Mol Biol 2007, 14:194-199.
• [41]Demirov DG, Ono A, Orenstein JM, Freed EO: Overexpression of the N-terminal domain of TSG101 inhibits HIV-1 budding by blocking late domain function. Proc Natl Acad Sci USA 2002, 99:955-960.
• [42]Huang M, Orenstein JM, Martin MA, Freed EO: p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. J Virol 1995, 69:6810-6818.
• [43]Goff A, Ehrlich LS, Cohen SN, Carter CA: Tsg101 control of human immunodeficiency virus type 1 Gag trafficking and release. J Virol 2003, 77:9173-9182.
• [44]Kim HC, Huibregtse JM: Polyubiquitination by HECT E3s and the determinants of chain type specificity. Mol Cell Biol 2009, 29:3307-3318.
• [45]Katzmann DJ, Babst M, Emr SD: Ubiquitin-dependent sorting into the multivesicular body pathway requires the function of a conserved endosomal protein sorting complex, ESCRT-I. Cell 2001, 106:145-155.
• [46]Bilodeau PS, Urbanowski JL, Winistorfer SC, Piper RC: The Vps27p Hse1p complex binds ubiquitin and mediates endosomal protein sorting. Nat Cell Biol 2002, 4:534-539.
• [47]Gruenberg J, Stenmark H: The biogenesis of multivesicular endosomes. Nat Rev Mol Cell Biol 2004, 5:317-323.
• [48]MacDonald C, Buchkovich NJ, Stringer DK, Emr SD, Piper RC: Cargo ubiquitination is essential for multivesicular body intralumenal vesicle formation. EMBO Rep 2012, 13:331-338.
• [49]Jouvenet N, Zhadina M, Bieniasz PD, Simon SM: Dynamics of ESCRT protein recruitment during retroviral assembly. Nat Cell Biol 2011, 13:394-401.
• [50]Adachi A, Gendelman HE, Koenig S, Folks T, Willey R, Rabson A, Martin MA: Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone. J Virol 1986, 59:284-291.
• [51]Colicelli J, Goff SP: Isolation of an integrated provirus of Moloney murine leukemia virus with long terminal repeats in inverted orientation: integration utilizing two U3 sequences. J Virol 1988, 62:633-636.
• [52]Li F, Chen C, Puffer BA, Montelaro RC: Functional replacement and positional dependence of homologous and heterologous L domains in equine infectious anemia virus replication. J Virol 2002, 76:1569-1577.
• [53]Dussupt V, Javid MP, Abou-Jaoude G, Jadwin JA, de La Cruz J, Nagashima K, Bouamr F: The nucleocapsid region of HIV-1 Gag cooperates with the PTAP and LYPXnL late domains to recruit the cellular machinery necessary for viral budding. PLoS Pathog 2009, 5:e1000339.
• [54]Dussupt V, Sette P, Bello NF, Javid MP, Nagashima K, Bouamr F: Basic residues in the nucleocapsid domain of Gag are critical for late events of HIV-1 budding. J Virol 2011, 85:2304-2315.
• [55]Kattenhorn LM, Korbel GA, Kessler BM, Spooner E, Ploegh HL: A deubiquitinating enzyme encoded by HSV-1 belongs to a family of cysteine proteases that is conserved across the family Herpesviridae. Mol Cell 2005, 19:547-557.
• [56]Hermida-Matsumoto L, Resh MD: Localization of human immunodeficiency virus type 1 Gag and Env at the plasma membrane by confocal imaging. J Virol 2000, 74:8670-8679.
• [57]Sette P, Mu R, Dussupt V, Jiang J, Snyder G, Smith P, Xiao TS, Bouamr F: The Phe105 loop of Alix Bro1 domain plays a key role in HIV-1 release. Structure 2011, 19:1485-1495.
• [58]Montelaro RC, Parekh B, Orrego A, Issel CJ: Antigenic variation during persistent infection by equine infectious anemia virus, a retrovirus. J Biol Chem 1984, 259:10539-10544.
• [59]Wei X, Decker JM, Liu H, Zhang Z, Arani RB, Kilby JM, Saag MS, Wu X, Shaw GM, Kappes JC: Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy. Antimicrob Agents Chemother 2002, 46:1896-1905.
• [60]Sette P, Dussupt V, Bouamr F: Identification of the HIV-1 NC binding interface in Alix Bro1 reveals a role for RNA. J Virol 2012, 86:11608-11615.